Reticulocyte count and hemoglobin concentration predict survival in Candidates for liver transplantation

Transplantation

Volumn 97, Issue 4, 2014, Pages 463-469

  Parker, Richard ^a,b   Armstrong, Matthew J ^a,b   Bruns, Tony ^a,c   Hodson, James ^b   Rowe, Ian A C ^a,b   Corbett, Chris D T ^a,b   Reuken, Philip A ^c   Gunson, Bridget K ^a   Houlihan, Diarmaid D ^a,b   Stephenson, Barney ^a,b   Malessa, Christina ^c   Lester, William ^d   Ferguson, James W ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c JENA UNIVERSITY HOSPITAL   (Germany)

^d UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Hemoglobin; Liver transplantation; Reticulocyte count

Indexed keywords

HEMOGLOBIN;

ACCURACY; ADULT; ANEMIA; ARTICLE; COHORT ANALYSIS; END STAGE LIVER DISEASE; FEMALE; GERMANY; HEMOGLOBIN DETERMINATION; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTIVE VALUE; PRIORITY JOURNAL; RETICULOCYTE COUNT; RETROSPECTIVE STUDY; SURVIVAL RATE; UNITED KINGDOM;

END STAGE LIVER DISEASE; ERYTHROCYTES; FEMALE; HEMOGLOBINS; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RETICULOCYTE COUNT; RETICULOCYTES; RETROSPECTIVE STUDIES; RISK; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84896723072     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000437429.12356.03     Document Type: Article

References (33)

1. Rustgi VK. The epidemiology of hepatitis C infection in the United States. J Gastroenterol 2007; 42: 513
2. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009; 27: 1485
3. Fleming KM, Aithal GP, Solaymani-Dodaran M, et al. Incidence and prevalence of cirrhosis in the United Kingdom, 1992Y2001: A general population-based study. J Hepatol 2008; 49: 732
4. US Department of Health and Human Services website. HRSA/OPTN data reports accessed 30th December 2011
5. NHS Blood and Transplant website. Liver Activity. 2011 accessed December 2011
6. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864
7. Kamath PS,WiesnerRH,Malinchoc M, et al. Amodel to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464
8. Freeman RB Jr, Wiesner RH, Harper A, et al. The new liver allocation system: Moving toward evidence-based transplantation policy. Liver Transpl 2002; 8: 851
9. Cholongitas E, Marelli L, Kerry A, et al. Female liver transplant recipients with the same GFR as male recipients have lower MELD scoresVa systematic bias. Am J Transplant 2007; 7: 685
10. Bambha KM, Biggins SW. Inequities of the Model for End-Stage Liver Disease: An examination of current components and future additions. Curr Opin Organ Transplant 2008; 13: 227
11. Gotthardt D,Weiss K, Baumgärtner M, et al. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation. BMC Gastroenterol 2009; 9: 72
12. Ruf AE, Kremers WK, Chavez LL, et al. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005; 11: 336
13. Biggins SW, Kim W. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006; 130: 1652
14. Luca A, Angermayr B, Bertolini G, et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl 2007; 13: 1174
15. LeiseMD, KimW, KremersWK, et al. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation. Gastroenterology 2011; 140: 1952
16. Barber K, Madden S, Allen J, et al. Elective liver transplant list mortality: Development of a United Kingdom end-stage liver disease score. Transplantation 2011; 92: 469
17. Qamar AA, Grace ND, Groszmann RJ, et al. Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis. Clin Gastroenterol Hepatol 2009; 7: 689
18. Realdi G, Fattovich G, Hadziyannis S, et al. Survival and prognostic factors in patients with compensated cirrhosis type b: A multicentre study. J Hepatol 1994; 21: 656
19. Madhotra R, Mulchay HE, Wilner I, et al. Prediction of esophageal varices in patients with cirrhosis. J Clin Gastroenterol 2002; 34: 81
20. Jiang GQ, Bai DS, Chen P, et al. Starting haemoglobin value predicts early phase prognosis after liver transplantation. Transplant Proc 2011; 43: 1669
21. Kamperidis N, Heneghan MA, Heaton N, et al. Haemoglobin level prior to liver transplantation: Does it predict the outcome? Gut 2011; 60(Suppl 2): A38
22. Weismüller TJ, Kirchner GI, Scherer MN, et al. Serum ferritin concentration and transferrin saturation before liver transplantation predict decreased long-Term recipient survival. Hepatology 2011; 54: 2114
23. Walker NM, Stuart KA, Ryan RJ, et al. Serum ferritin concentration predicts mortality in patients awaiting liver transplantation. Hepatology 2010; 51: 1683
24. UNOS database http://optn.transplant.hrsa.gov/latestData/rptData.asp accessed June 2013
25. Tarone RE, Ware J. On distribution-free tests for equality of survival distributions. Biometrika 1977; 64: 156
26. Berzigotti A, Seijo S, Arena U, et al. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology 2013; 144: 102
27. Kalambokis G, Tsianos EV. Endotoxaemia in the pathogenesis of cytopenias in liver cirrhosis. Could oral antibiotics raise blood counts? Med Hypotheses 2011; 76: 105
28. Sullivan LW, Herbert V. Suppression of hematopoiesis by ethanol. J Clin Invest 1964; 43: 2048
29. Cooper RA. Anemia with spur cells: A red cell defect acquired in serum and modified in the circulation. J Clin Invest 1969; 48: 1820
30. Patt CH, Fairbanks KD, Thuluvath PJ. Renal insufficiency may partly explain chronic anemia in patients awaiting liver transplantation. Dig Dis Sci 2004; 49: 629
31. Gines, P, Schrier RW. Renal failure in cirrhosis. N Engl J Med 2009; 361: 1279
32. Morse EE. Mechanisms of hemolysis in liver disease. Ann Clin Lab Sci 1990; 20: 169
33. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361